Bubs Australia secures permanent FDA nod for infant formula sales in US, shares jump

Bubs Australia said on Monday it secured permanent authorisation from the U.S. Food and ​Drug Administration to sell three infant formula ‌products in the country, putting the stock on course for its ...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。